Hypertension

This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics and renal denervation therapy.

Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of lorundrostat, a highly selective aldosterone synthase inhibitor, in individuals with uncontrolled hypertension (uHTN) and resistant hypertension (rHTN).

News | Cardiovascular Clinical Studies

Mineralys Therapeutics Presents Target-HTN Phase 2 Trial Results at 2023 AHA Hypertension Scientific Sessions

September 12, 2023 — Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of ...

September 12, 2023

Recipient of the Harry Goldblatt Award for New Investigators from the American Heart Association’s 2023 Hypertension Council

News | Hypertension

Faulkner to be Honored by American Heart Association

September 7, 2023 —Jessica Faulkner, PhD, a physiologist whose research is focused on sex differences in cardiovascular ...

September 07, 2023

A new study in the AHA journal Hypertension finds SARS-CoV-2 infection is significantly associated with the development of high blood pressure in adults with preexisting heart conditions or those who were older, black or male.

News | Hypertension

Study Reveals COVID-19 May Trigger New-onset Hypertension

August 22, 2023 — An analysis of electronic medical records for more than 45,000 people found that COVID-19 infection ...

August 22, 2023

The Society for Cardiovascular Angiography & Interventions (SCAI) has released a position statement on Renal Denervation (RDN), emphasizing patient selection, optimal techniques, competence, training, and institutional recommendations

News | Renal Denervation

New SCAI Position Statement Highlights the Role of Renal Denervation in Hypertension Treatment

August 21, 2023 — The Society for Cardiovascular Angiography & Interventions (SCAI) has released a position statement on ...

August 21, 2023

New U.S. patent provides intellectual property (IP) protection until December 2040, and may qualify for term extension beyond 2040

News | Hypertension

Tenax Therapeutics Issued U.S. Patent for Oral Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

July 26, 2023 — Tenax Therapeutics, Inc, a specialty pharmaceutical company focused on identifying, developing and ...

July 26, 2023

Research shows that patients have better outcomes when they are treated at an accredited center, such as the Hypertension Center in the Smidt Heart Institute, by physicians specialized in the disease. Photo by Getty.

News | Hypertension

Smidt Heart Institute’s Hypertension Center Earns Accreditation

July 25, 2023 — The Hypertension Center in the Smidt Heart Institute at Cedars-Sinai has earned accreditation from the A ...

July 25, 2023

The results of a long-term analysis show necessary adjustments in international guidelines as well as in diagnosis and treatment

News | Hypertension

Chronic Thromboembolic Pulmonary Vascular Disease and Left Heart Disease are not Mutually Exclusive

April 28, 2023 — A long-term analysis designed by Christian Gerges and Irene Lang at the Department of Medicine II of ...

April 28, 2023

Findings from a clinical trial on treating hypertension, published in the Journal of the American Medical Association (JAMA), highlight the potential of personalized medicine in cardiovascular care, and in the future, could improve treatment adherence, patient outcomes, and the cost-effectiveness of blood pressure-lowering medication.

News | Hypertension

Study on Blood Pressure Treatment Sheds Light on Value of Personalized Medicine in Cardiovascular Care

April 12, 2023 — Results from the Precision Hypertension Care Study (PHYSIC) showed that personalized blood pressure ...

April 12, 2023

The need for appropriate diagnosis, treatment and reduction of lifestyle risk factors for high blood pressure in youth were outlined in a new scientific statement from the American Heart Association, published March 30 in the Association’s Hypertension journal.

News | Hypertension

Children with High Blood Pressure in Spotlight with AHA Journal Scientific Statement

April 4, 2023 — The need for appropriate diagnosis, treatment and reduction of lifestyle risk factors for high blood ...

April 04, 2023

Royal Philips has announced the debut of a comprehensive approach to telehealth with Philips Virtual Care Management. The solution’s condition-specific protocols now include heart disease and hypertension, as well as other chronic conditions. Photo credit: Getty Images

News | Remote Monitoring

Philips Debuts Remote Patient Management Solution

March 28, 2023 — Royal Philips has announced its debut of Philips Virtual Care Management, a comprehensive approach to ...

March 28, 2023

Use of an antihypertensive to lower blood pressure in obese patients was found effective, according to Target-HTN Trial results presented during the 2023 American College of Cardiology Scientific Session.

News | ACC

Data from Target-HTN Trial Released at ACC23 Supports Use of Antihypertensive to Reduce Blood Pressure in Obese Patients

March 9, 2023 — Positive results from a Mineralys Therapeutics study, the Target-HTN Phase 2 trial, demonstrated ...

March 09, 2023

Kelly Chin, MD, professor of medicine and director of the pulmonary hypertension program at UT Southwestern Medical Center in Dallas

News | Hypertension

Fixed-Dose Combination Pill Outperforms Monotherapy for Pulmonary Hypertension

March 6, 2023 — Patients with pulmonary arterial hypertension (high blood pressure in the arteries that supply the lungs ...

March 06, 2023

Amrita Mukhopadhyay, MD, cardiologist and clinical investigator at NYU Grossman School of Medicine in New York City

News | Heart Failure

Prescribing of Key Heart Failure Medications Improved with Tailored Digital Alerts

March 5, 2023 — Doctors who received customized electronic health record (EHR) alerts for specific patients were 2.5 ...

March 05, 2023

Primary Results from RADIANCE II Trial Published in JAMA and Results of Pooled Analysis from Three RADIANCE Studies Published in JAMA Cardiology

News | Renal Denervation

ReCor Medical Announces Two Concurrent JAMA Network Publications of Study Results on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension

March 2, 2023 — ReCor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced that primary ...

March 02, 2023

The risk of hypertension increases significantly with orthostatic circulatory disorders.

News | Hypertension

RUDN University Doctors Tested a Novel Approach to Detecting Future Arterial Hypertension in Healthy People

January 17, 2023 — Arterial hypertension(AH), or high blood pressure, can be prevented if diagnosed pre-clinically on ...

January 17, 2023